跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 124,858 条关于
“serous endometrial cancer”
全部
124,858
临床试验
106,027
药物
2,535
机构
1,139
资讯
15,157
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
2年前
Immunotherapy Advances in Endometrial Cancer: Focus Shifts to pMMR Disease Following Success in dMMR Population
去年
DUO Trial Reveals Promise for Durvalumab-Olaparib Combination in Early-Stage Endometrial Cancer
去年
FR-alpha and B7-H4 Expression Found in Over 80% of Endometrial Cancer Cases, Supporting ADC Development
2年前
Targeted Therapies Show Promise in High-Grade Serous Ovarian Cancer Treatment
去年
Puxitatug Samrotecan Shows Promise in Advanced Endometrial Cancer with 38% Response Rate
去年
Cadonilimab Plus Lenvatinib Shows Promise in Advanced Endometrial Cancer After Platinum Failure
去年
Olaparib-Durvalumab Combination Shows Broad PFS Benefits Across pMMR Endometrial Cancer Subgroups
去年
Adavosertib Shows Promise in Uterine Serous Carcinoma Despite Tolerability Challenges
2年前
Roche's Bevacizumab Under Evaluation for Endometrial Cancer Treatment
第 1 页，共 1516 页
上一页
下一页
